22.06.2022 11:43:23

DGAP-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

DGAP Preliminary announcement financial reports: Heidelberg Pharma AG / Preliminary announcement on the disclosure of financial statements
Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

22.06.2022 / 11:43
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: July 12, 2022
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen/finanzberichte

Language: English
Date of disclosure: July 12, 2022
Address: https://heidelberg-pharma.com/en/press-and-investors/announcements/financial-reports


22.06.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News DGAP News Service

1381339  22.06.2022 

fncls.ssp?fn=show_t_gif&application_id=1381339&application_name=news&site_id=smarthouse

Analysen zu Heidelberg Pharma AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Heidelberg Pharma AG 2,89 9,47% Heidelberg Pharma AG